Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 437123, 12 pages
http://dx.doi.org/10.1155/2013/437123
Research Article

Stimulation of MMP-1 and CCL2 by NAMPT in PDL Cells

1Experimental Dento-Maxillo-Facial Medicine, Center of Dento-Maxillo-Facial Medicine, University of Bonn, 53111 Bonn, Germany
2Clinical Research Unit 208, Center of Dento-Maxillo-Facial Medicine, University of Bonn, Welschnonnenstraße 17, 53111 Bonn, Germany
3Department of Periodontology, Laboratory of Oral Microbiology, University of Bern, 3010 Bern, Switzerland
4Department of Diagnosis and Surgery, School of Dentistry, SP, UNESP, 14801-903 Araraquara, Brazil
5Institute of Human Genetics, Biomedical Center, University of Bonn, 53127 Bonn, Germany
6Division of Medical Genetics, University Hospital Basel and Department of Biomedicine, University of Basel, 4058 Basel, Switzerland
7Bonn-Aachen International Center for IT, Algorithmic Bioinformatics, University of Bonn, 53113 Bonn, Germany
8Department of Periodontology, Operative and Preventive Dentistry, University of Bonn, 53111 Bonn, Germany
9Department of Orthodontics, University of Bonn, 53111 Bonn, Germany

Received 14 May 2013; Accepted 18 July 2013

Academic Editor: Timo Sorsa

Copyright © 2013 Marjan Nokhbehsaim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. L. Pihlstrom, B. S. Michalowicz, and N. W. Johnson, “Periodontal diseases,” The Lancet, vol. 366, no. 9499, pp. 1809–1820, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Sbordone and C. Bortolaia, “Oral microbial biofilms and plaque-related diseases: microbial communities and their role in the shift from oral health to disease,” Clinical Oral Investigations, vol. 7, no. 4, pp. 181–188, 2003. View at Google Scholar · View at Scopus
  3. J. M. Albandar, “Commentary: underestimation of periodontitis in nhanes surveys,” Journal of Periodontology, vol. 82, no. 3, pp. 337–341, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Beikler and T. F. Flemmig, “Oral biofilm-associated diseases: trends and implications for quality of life, systemic health and expenditures,” Periodontology 2000, vol. 55, no. 1, pp. 87–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Suvan, F. D'Aiuto, D. R. Moles, A. Petrie, and N. Donos, “Association between overweight/obesity and periodontitis in adults. A systematic review,” Obesity Reviews, vol. 12, no. 501, pp. e381–e404, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. G. J. Seymour, P. J. Ford, M. P. Cullinan, S. Leishman, and K. Yamazaki, “Relationship between periodontal infections and systemic disease,” Clinical Microbiology and Infection, vol. 13, no. 4, pp. 3–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Conde, M. Scotece, R. Gómez et al., “Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity,” BioFactors, vol. 37, no. 6, pp. 413–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. R. Moschen, R. R. Gerner, and H. Tilg, “Pre-b cell colony enhancing factor/nampt/visfatin in inflammation and obesityrelated disorders,” Current Pharmaceutical Design, vol. 16, no. 17, pp. 1913–1920, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. Y.-H. Chang, D.-M. Chang, K.-C. Lin, S.-J. Shin, and Y.-J. Lee, “Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review,” Diabetes/Metabolism Research and Reviews, vol. 27, no. 6, pp. 515–527, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Taskesen, B. Kirel, and T. Us, “Serum visfatin levels, adiposity and glucose metabolism in obese adolescents,” Journal of Clinical Research in Pediatric Endocrinology, vol. 4, pp. 76–81, 2012. View at Google Scholar
  11. L. Q. Zhang, D. P. Heruth, and S. Q. Ye, “Nicotinamide phosphoribosyltransferase in human diseases,” Journal of Bioanalysis and Biomedicine, vol. 3, no. 1, pp. 13–25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. R. Pradeep, R. N. M. Raghavendra N.M., M. V. R. Prasad, R. Kathariya, S. P. Patel, and A. Sharma, “Gingival crevicular fluid and serum visfatin concentration: their relationship in periodontal health and disease,” Journal of Periodontology, vol. 82, no. 9, pp. 1314–1319, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. R. Pradeep, N. M. Raghavendra, A. Sharma et al., “Association of serum and crevicular visfatin levels in periodontal health and disease with type 2 diabetes mellitus,” Journal of Periodontology, vol. 83, no. 5, pp. 629–634, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Nokhbehsaim, B. Deschner, J. Winter et al., “Interactions of regenerative, inflammatory and biomechanical signals on bone morphogenetic protein-2 in periodontal ligament cells,” Journal of Periodontal Research, vol. 46, no. 3, pp. 374–381, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Nokhbehsaim, J. Winter, B. Rath, A. Jäger, S. Jepsen, and J. Deschner, “Effects of enamel matrix derivative on periodontal wound healing in an inflammatory environment in vitro,” Journal of Clinical Periodontology, vol. 38, no. 5, pp. 479–490, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Nokhbehsaim, B. Deschner, J. Winter et al., “Anti-inflammatory effects of EMD in the presence of biomechanical loading and interleukin-1β in vitro,” Clinical Oral Investigations, vol. 16, no. 1, pp. 275–283, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. S. M. Lin, P. Du, W. Huber, and W. A. Kibbe, “Model-based variance-stabilizing transformation for Illumina microarray data,” Nucleic Acids Research, vol. 36, no. 2, article e11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. B. M. Bolstad, R. A. Irizarry, M. Åstrand, and T. P. Speed, “A comparison of normalization methods for high density oligonucleotide array data based on variance and bias,” Bioinformatics, vol. 19, no. 2, pp. 185–193, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Du, W. A. Kibbe, and S. M. Lin, “lumi: a pipeline for processing Illumina microarray,” Bioinformatics, vol. 24, no. 13, pp. 1547–1548, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. T. Leek and J. D. Storey, “A general framework for multiple testing dependence,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 48, pp. 18718–18723, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. G. K. Smyth, “Linear models and empirical bayes methods for assessing differential expression in microarray experiments,” Statistical Applications in Genetics and Molecular Biology, vol. 3, no. 1, article 3, 2004. View at Google Scholar · View at Scopus
  22. M. E. Ritchie, D. Diyagama, J. Neilson et al., “Empirical array quality weights in the analysis of microarray data,” BMC Bioinformatics, vol. 7, article 261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Benjamini and Y. Hochberg, “Controlling the false discovery rate: a practical and powerful approach to multiple testing,” Journal of the Royal Statistical Society B, vol. 57, pp. 89–300, 1995. View at Google Scholar
  24. G. K. Smyth, “Limma: linear models for microarray data,” in Bioinformatics and Computational Biology Solutions Using R and Bioconductor, R. Gentleman, V. Carey, W. Huber, R. Irizarry, and S. Dudoit, Eds., pp. 397–420, Springer, New York, NY, USA, 2005. View at Google Scholar
  25. P. A. Arakaki, M. R. Marques, and M. C. L. G. Santos, “MMP-1 polymorphism and its relationship to pathological processes,” Journal of Biosciences, vol. 34, no. 2, pp. 313–320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A.-L. Ejeil, S. Igondjo-Tchen, S. Ghomrasseni, B. Pellat, G. Godeau, and B. Gogly, “Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva,” Journal of Periodontology, vol. 74, no. 2, pp. 188–195, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Tüter, B. Kurtiş, and M. Serdar, “Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1,” Journal of Periodontology, vol. 73, no. 5, pp. 487–493, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. S. L. Deshmane, S. Kremlev, S. Amini, and B. E. Sawaya, “Monocyte chemoattractant protein-1 (MCP-1): an overview,” Journal of Interferon and Cytokine Research, vol. 29, no. 6, pp. 313–326, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. G. P. Garlet, W. Martins Jr., B. R. Ferreira, C. M. Milanezi, and J. S. Silva, “Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease,” Journal of Periodontal Research, vol. 38, no. 2, pp. 210–217, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Gupta, R. Chaturvedi, and A. Jain, “Role of monocyte chemoattractant protein-1 (MCP-1) as an immune-diagnostic biomarker in the pathogenesis of chronic periodontal disease,” Cytokine, vol. 61, pp. 892–897, 2013. View at Google Scholar
  31. B. Kurtiş, G. Tüter, M. Serdar et al., “Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis,” Journal of Periodontology, vol. 76, no. 11, pp. 1849–1855, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Brentano, O. Schorr, C. Ospelt et al., “Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities,” Arthritis and Rheumatism, vol. 56, no. 9, pp. 2829–2839, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. S. W. Liu, S. B. Qiao, J. S. Yuan, and D. Q. Liu, “Visfatin stimulates production of monocyte chemotactic protein-1 and interleukin-6 in human vein umbilical endothelial cells,” Hormone and Metabolic Research, vol. 41, no. 4, pp. 281–286, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Sommer, S. Kralisch, N. Kloting et al., “Visfatin is a positive regulator of MCP-1 in human adipocytes in vitro and in mice in vivo,” Obesity, vol. 18, no. 8, pp. 1486–1492, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. E. D. Adamson and D. Mercola, “Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival,” Tumor Biology, vol. 23, no. 2, pp. 93–102, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. V. Baron, E. D. Adamson, A. Calogero, G. Ragona, and D. Mercola, “The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin,” Cancer Gene Therapy, vol. 13, no. 2, pp. 115–124, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. V. S. Ten and D. J. Pinsky, “Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction,” Current Opinion in Critical Care, vol. 8, no. 3, pp. 242–250, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. S. B. McMahon and J. G. Monroe, “The role of early growth response gene 1 (egr-1) in regulation of the immune response,” Journal of Leukocyte Biology, vol. 60, no. 2, pp. 159–166, 1996. View at Google Scholar · View at Scopus
  39. S. L. Teitelbaum, “The osteoclast and its unique cytoskeleton,” Annals of the New York Academy of Sciences, vol. 1240, no. 1, pp. 14–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. R. A. Colvin, T. K. Means, T. J. Diefenbach et al., “Synaptotagmin-mediated vesicle fusion regulates cell migration,” Nature Immunology, vol. 11, no. 6, pp. 495–502, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. K. T. Fowler, N. W. Andrews, and J. W. Huleatt, “Expression and function of synaptotagmin VII in CTLs,” Journal of Immunology, vol. 178, no. 3, pp. 1498–1504, 2007. View at Google Scholar · View at Scopus
  42. G. Glavan, R. Schliebs, and M. Živin, “Synaptotagmins in neurodegeneration,” Anatomical Record, vol. 292, no. 12, pp. 1849–1862, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Kato, K. Uzawa, T. Onda et al., “Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma,” International Journal of Oncology, vol. 28, no. 4, pp. 873–881, 2006. View at Google Scholar · View at Scopus
  44. S. Windhorst, R. Fliegert, C. Blechner et al., “Inositol 1,4,5-trisphosphate 3-kinase-A is a new cell motility-promoting protein that increases the metastatic potential of tumor cells by two functional activities,” Journal of Biological Chemistry, vol. 285, no. 8, pp. 5541–5554, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. H. K. Il, K. P. Soon, T. H. Soon et al., “Inositol 1,4,5-trisphosphate 3-kinase A functions as a scaffold for synaptic rac signaling,” Journal of Neuroscience, vol. 29, no. 44, pp. 14039–14049, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Krizsan-Agbas, T. Pedchenko, and P. G. Smith, “Neurotrimin is an estrogen-regulated determinant of peripheral sympathetic innervation,” Journal of Neuroscience Research, vol. 86, no. 14, pp. 3086–3095, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Chen, O. Gil, Y. Q. Ren, G. Zanazzi, J. L. Salzer, and D. E. Hillman, “Neurotrimin expression during cerebellar development suggests roles in axon fasciculation and synaptogenesis,” Journal of Neurocytology, vol. 30, no. 11, pp. 927–937, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. J. L. Bell, K. Wächter, B. Mühleck et al., “Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?” Cellular and Molecular Life Sciences, vol. 70, no. 15, pp. 2657–2675, 2013. View at Publisher · View at Google Scholar
  49. R. Suvasini, B. Shruti, B. Thota et al., “Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2,” Journal of Biological Chemistry, vol. 286, no. 29, pp. 25882–25890, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. C. A. Staton, I. Kumar, M. W. R. Reed, and N. J. Brown, “Neuropilins in physiological and pathological angiogenesis,” Journal of Pathology, vol. 212, no. 3, pp. 237–248, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. J. R. L. Wild, C. A. Staton, K. Chapple, and B. M. Corfe, “Neuropilins: expression and roles in the epithelium,” International Journal of Experimental Pathology, vol. 93, no. 2, pp. 81–103, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. I. C. Zachary, “How neuropilin-1 regulates receptor tyrosine kinase signalling: the knowns and known unknowns,” Biochemical Society Transactions, vol. 39, no. 6, pp. 1583–1591, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Mizui and H. Kikutani, “Neuropilin-1: the glue between regulatory T cells and dendritic cells?” Immunity, vol. 28, no. 3, pp. 302–303, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Schwenk, M. Metz, G. Zolles et al., “Native GABAB receptors are heteromultimers with a family of auxiliary subunits,” Nature, vol. 465, no. 7295, pp. 231–235, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Adya, B. K. Tan, J. Chen, and H. S. Randeva, “Nuclear factor-κb induction by visfatin in human vascular endothelial cells,” Diabetes Care, vol. 31, no. 4, pp. 758–760, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. Fan, S. Meng, Y. Wang, J. Cao, and C. Wang, “Visfatin/PBEF/Nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-κB signaling pathway,” International Journal of Molecular Medicine, vol. 27, no. 4, pp. 607–615, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. A. V. Nogueira, M. Nokhbehsaim, S. Eick et al., “Regulation of visfatin by microbial and biomechanical signals in PDL cells,” Clinical Oral Investigations. In press.
  58. M. Gosset, F. Berenbaum, C. Salvat et al., “Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis,” Arthritis and Rheumatism, vol. 58, no. 5, pp. 1399–1409, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. C. E. Kendal and G. D. Bryant-Greenwood, “Pre-B-cell colony-enhancing factor (PBEF/Visfatin) gene expression is modulated by NF-κB and AP-1 in human amniotic epithelial cells,” Placenta, vol. 28, no. 4, pp. 305–314, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. M. R. Williams, N. Kataoka, Y. Sakurai, C. M. Powers, S. G. Eskin, and L. V. McIntire, “Gene expression of endothelial cells due to interleukin-1 beta stimulation and neutrophil transmigration,” Endothelium, vol. 15, no. 1-2, pp. 73–84, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Murakami, A. Kawata, Y. Seki et al., “Comparative inhibitory effects of magnolol, honokiol, eugenol and bis-eugenol on cyclooxygenase-2 expression and nuclear factor-kappa B activation in RAW264. 7 macrophage-like cells stimulated with fimbriae of Porphyromonas gingivalis,” In Vivo, vol. 26, pp. 941–950, 2012. View at Google Scholar
  62. D. Reddi, S. J. Brown, and G. N. Belibasakis, “Porphyromonas gingivalis induces RANKL in bone marrow stromal cells: involvement of the p38 MAPK,” Microbial Pathogenesis, vol. 51, no. 6, pp. 415–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Dunne and L. A. J. O'Neill, “The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense,” Science"s STKE, vol. 2003, no. 171, article re3, 2003. View at Google Scholar · View at Scopus
  64. J.-K. Lee, S.-H. Kim, E. C. Lewis, T. Azam, L. L. Reznikov, and C. A. Dinarello, “Differences in signaling pathways by IL-1β and IL-18,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 23, pp. 8815–8820, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. S. C. Holt and J. L. Ebersole, “Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the “red complex”, a prototype polybacterial pathogenic consortium in periodontitis,” Periodontology 2000, vol. 38, pp. 72–122, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. K. Nakayama, “Molecular genetics of Porphyromonas gingivalis: gingipains and other virulence factors,” Current Protein and Peptide Science, vol. 4, no. 6, pp. 389–395, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. J. Potempa, A. Sroka, T. Imamura, and J. Travis, “Gingipains, the major cysteine proteinases and virulence factors of Porphyromonas gingivalis: structure, function and assembly of multidomain protein complexes,” Current Protein and Peptide Science, vol. 4, no. 6, pp. 397–407, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. Y.-C. Chang, F.-M. Huang, S.-F. Yang et al., “Induction of cyclooxygenase-2 mRNA and protein expression in human pulp cells stimulated with black-pigmented bacteroides,” Journal of Endodontics, vol. 29, no. 4, pp. 240–243, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. Hayashi, M. Kobayashi, H. Kuwata et al., “Interferon-γ and interleukin 4 inhibit interleukin 1β-induced delayed prostagilandin E2 generation through suppression of cyclooxugenase-2 expression in human fibroblasts,” Cytokine, vol. 12, no. 6, pp. 603–612, 2000. View at Publisher · View at Google Scholar · View at Scopus